BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock Income Statement
NASDAQ:BIAF - Nasdaq - US09076W1099 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.36M | 2.53M | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 5.98M | 1.74M | 0.00 | N/A | N/A | |||
| Gross Profit | 3.38M | 791.60K | 0.00 | N/A | N/A | |||
| Operating Expenses | 12.33M | 8.76M | 4.01M | 2.21M | 2.60M | |||
| Research and Development | 1.78M | 1.72M | 1.29M | 1.33M | 1.61M | |||
| Selling, General, and Administrative Expenses | 9.94M | 6.79M | 2.73M | 880.00K | 990.00K | |||
| Operating Income | -8.95M | -7.97M | -4.01M | -2.21M | -2.60M | |||
| Interest Income/Expense | -74.90K | 85.00K | -4.35M | -4.36M | -4.66M | |||
| Other Income/Expense | 100.00 | -27.80K | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | 210.00K | 240.00K | 0.00 | |||
| Income Before Taxes | -9.03M | -7.92M | -8.15M | -6.32M | -7.27M | |||
| Income Tax | 11.70K | 21.00K | 0.00 | 0.00 | 0.00 | |||
| Net Income | -9.04M | -7.94M | -8.15M | -6.33M | -7.27M | |||
| EBITDA | -8.35M | -7.72M | -4.00M | N/A | -2.58M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.75 | -0.91 | -1.81 | -2.32 | -2.66 | |||
| Statistics | ||||||||
| Gross Profit Margin | 36.09% | 31.26% | N/A | N/A | N/A | |||
| Profit Margin | -96.56% | -313.41% | N/A | N/A | N/A | |||
| Operating Profit Margin | -95.64% | -314.84% | N/A | N/A | N/A | |||
All data in USD